FDA Committee Votes Down Duchenne Drug

(MedPage Today) -- An FDA panel said that trial data did not provide substantial evidence showing that investigational deramiocel was effective in treating cardiomyopathy among patients with Duchenne muscular dystrophy.
In a 9-3 vote, the FDA...